The national law firm of Parker Waichman LLP has filed a lawsuit on behalf of a woman in Kentucky who developed bladder cancer allegedly because she used the type 2 diabetes drug Actos. The lawsuit was filed in U.S. District Court for the Western District of Louisiana against Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceutical Company Limited and Eli Lilly and Co. The suit joins many others which have been consolidated in multidistrict litigation.
According to the lawsuit, the plaintiff used Actos as prescribed from 2007 to 2010, and developed bladder cancer in July 2009. The suit says that the plaintiff would not have taken Actos had Takeda and Eli Lilly adequately informed consumers and their physicians about the dangers associated with the drug, including the increased risk of bladder cancer when the drug is used for a year or more.
In the lawsuit, the plaintiff is claiming severe physical and mental pain and suffering, past and future permanent injuries and emotional distress, as well as economic loss due to medical expenses, and living-related expenses as a result of a new lifestyle.
Parker Waichman says that the FDA issued a Safety Announcement last year warning that users may be more likely to develop bladder cancer after one year of use. Jerrold S. Parker, co-founder of Parker Waichman has been appointed to the Plaintiffs’ Steering Committee.
/* Style Definitions */
mso-padding-alt:0in 5.4pt 0in 5.4pt;
mso-bidi-font-family:”Times New Roman”;
Kentucky Woman Files Actos Bladder Cancer Lawsuit against Takeda